CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphoma

Chemotherapy and hematopoietic stem cell transplantation are effective treatments for most Hodgkin lymphoma patients, however there remains a need for better tumor-specific target therapy in Hodgkin lymphoma patients with refractory or relapsed disease. Herein, we demonstrate that membrane CD83 is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ziduo, Ju, Xinsheng, Lee, Kenneth, Clarke, Candice, Hsu, Jennifer L., Abadir, Edward, Bryant, Christian E., Pears, Suzanne, Sunderland, Neroli, Heffernan, Scott, Hennessy, Annemarie, Lo, Tsun-Ho, Pietersz, Geoffrey A., Kupresanin, Fiona, Fromm, Phillip D., Silveira, Pablo A., Tsonis, Con, Cooper, Wendy A., Cunningham, Ilona, Brown, Christina, Clark, Georgina J., Hart, Derek N.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865416/
https://www.ncbi.nlm.nih.gov/pubmed/29351987
http://dx.doi.org/10.3324/haematol.2017.178384

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865416/
https://www.ncbi.nlm.nih.gov/pubmed/29351987
http://dx.doi.org/10.3324/haematol.2017.178384

Ejemplares similares